Nastech Pharmaceutical Company Inc. 3,250,000 Shares Common Stock ($0.006 par value per Share) Underwriting AgreementUnderwriting Agreement • January 19th, 2007 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • New York
Each of the undersigned, Steven C. Quay, Chairman of the Board, President and Chief Executive Officer of Nastech Pharmaceutical Company Inc., a Delaware corporation (the “Company”), and Philip C. Ranker, Chief Financial Officer and Secretary of the Company, on behalf of the Company, does hereby certify pursuant to Section 6(i) of that certain Underwriting Agreement dated January 17, 2007 (the “Underwriting Agreement”) between the Company and UBS Securities LLC, that as of [date]:
AMENDMENT NO. 1 TO RIGHTS AGREEMENTRights Agreement • January 19th, 2007 • Nastech Pharmaceutical Co Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT NO. 1 TO RIGHTS AGREEMENT is entered into as of this 17th day of January, 2007 by and between Nastech Pharmaceutical Company Inc. (the “Company”) and American Stock Transfer & Trust Company (the “Rights Agent”).
